CS logo
small CS logo
SBEI HPE "Ural State Medical University" of MoH of RF based MBI "Central City Clinical Hospital #6"

Ekaterinburg, Sverdlovskaya Oblast, Russian Federation
Public university in Yekaterinburg
Ulitsa Repina, 3, Yekaterinburg, Sverdlovsk Oblast, 620014

About SBEI HPE "Ural State Medical University" of MoH of RF based MBI "Central City Clinical Hospital #6"


Ural State Medical University is a public medical university in Yekaterinburg, Sverdlovsk Oblast in the Ural region of Russia. It is the only institution of higher education in the Sverdlovsk Oblast that prepares doctors and pharmacists with higher education.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at SBEI HPE "Ural State Medical University" of MoH of RF based MBI "Central City Clinical Hospital #6"


During the past decade, SBEI HPE "Ural State Medical University" of MoH of RF based MBI "Central City Clinical Hospital #6" conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "SBEI HPE "Ural State Medical University" of MoH of RF based MBI "Central City Clinical Hospital #6"" #1 collaborator was "OCT Clinical Trials" with 2 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator and "Mene Research" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

Clinical Trials Conditions at SBEI HPE "Ural State Medical University" of MoH of RF based MBI "Central City Clinical Hospital #6"


According to Clinical.Site data, the most researched conditions in "SBEI HPE "Ural State Medical University" of MoH of RF based MBI "Central City Clinical Hospital #6"" are "Rheumatoid Arthritis" (2 trials). Many other conditions were trialed in "SBEI HPE "Ural State Medical University" of MoH of RF based MBI "Central City Clinical Hospital #6"" in a lesser frequency.

Clinical Trials Intervention Types at SBEI HPE "Ural State Medical University" of MoH of RF based MBI "Central City Clinical Hospital #6"


Most popular intervention types in "SBEI HPE "Ural State Medical University" of MoH of RF based MBI "Central City Clinical Hospital #6"" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Adalimumab 40mg q2w" (1 trials), "Olokizumab" (1 trials), "Olokizumab 64mg q2w" (1 trials), "Olokizumab 64mg q4w" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

Clinical Trials Genders at SBEI HPE "Ural State Medical University" of MoH of RF based MBI "Central City Clinical Hospital #6"


The vast majority of trials in "SBEI HPE "Ural State Medical University" of MoH of RF based MBI "Central City Clinical Hospital #6"" are 2 trials for "All" genders.

Clinical Trials Status at SBEI HPE "Ural State Medical University" of MoH of RF based MBI "Central City Clinical Hospital #6"


Currently, there are NaN active trials in "SBEI HPE "Ural State Medical University" of MoH of RF based MBI "Central City Clinical Hospital #6"". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in SBEI HPE "Ural State Medical University" of MoH of RF based MBI "Central City Clinical Hospital #6", undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in SBEI HPE "Ural State Medical University" of MoH of RF based MBI "Central City Clinical Hospital #6", 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".